Hedges Asset Management LLC
- SEC CIK
- 0001906202
- Latest filing
- Jul 27, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Hedges Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2026)
- 24,575
- Value
- $1.34M
- % of portfolio
- 0.9%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 24,575 | $1.34M | 0.9% | – | No prior filing | Holders |
| Q1 2026 | – | – | – | – | Not filed | Holders |
| Q4 2025 | 22,775 | $1.19M | 0.8% | +275+1.2% | Added | Holders |
| Q3 2025 | 22,500 | $1.46M | 1.1% | −2,200−8.9% | Reduced | Holders |
| Q2 2025 | 24,700 | $1.20M | 1.0% | −4,650−15.8% | Reduced | Holders |
| Q1 2025 | 29,350 | $998.8K | 0.7% | +5,000+20.5% | Added | Holders |
| Q4 2024 | 24,350 | $958.4K | 0.6% | +1,200+5.2% | Added | Holders |
| Q3 2024 | 23,150 | $1.09M | 0.7% | +1,350+6.2% | Added | Holders |
| Q2 2024 | 21,800 | $1.18M | 0.8% | +2,425+12.5% | Added | Holders |
| Q1 2024 | 19,375 | $1.32M | 0.9% | −2,000−9.4% | Reduced | Holders |
| Q4 2023 | 21,375 | $1.34M | 1.0% | −1,150−5.1% | Reduced | Holders |
| Q3 2023 | 22,525 | $1.02M | 0.9% | +3,575+18.9% | Added | Holders |
| Q2 2023 | 18,950 | $1.06M | 0.9% | +2,650+16.3% | Added | Holders |
| Q1 2023 | 16,300 | $737.2K | 0.6% | +625+4.0% | Added | Holders |
| Q4 2022 | 15,675 | $637.2K | 0.6% | +5,200+49.6% | Added | Holders |
| Q3 2022 | 10,475 | $685.0K | 0.7% | −1,900−15.4% | Reduced | Holders |
| Q2 2022 | 12,375 | $753.0K | 0.7% | +2,600+26.6% | Added | Holders |
| Q1 2022 | 9,775 | $614.0K | 0.5% | +1,425+17.1% | Added | Holders |
| Q4 2021 | 8,350 | $633.0K | 0.5% | – | No prior filing | Holders |